🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a single-arm, open-label, multi-centre drug-drug interaction ...
Status
Completed
Location
Research Site
Start Date
2022-11-07
Trial ID
NCT05573724
Treatments Being Tested
This Phase I, open-label study aims to study to absolute bioavailability of...
Status
Recruiting
Location
Research Site
Start Date
2025-04-02
Trial ID
NCT06713369
Treatments Being Tested
This research is designed to determine if experimental treatment with Antib...
Status
Recruiting
Location
Research Site
Start Date
2023-06-05
Trial ID
NCT05797168
Treatments Being Tested
This study will evaluate the safety, tolerability, pharmacokinetics (PK), p...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-06-02
Trial ID
NCT05367440
Treatments Being Tested
CONCORDE is a multi-institution, multi-arm, Phase IB study that will determ...
Status
Recruiting
Location
Belfast City Hospital
Start Date
2021-03-17
Trial ID
NCT04550104
Treatments Being Tested
This is a modular, phase I/ phase 1 b, open-label, multicentre study of cer...
Status
Active Not Recruiting
Location
Research Site
Start Date
2014-10-31
Trial ID
NCT02264678
Treatments Being Tested
This early phase I trial aims to determine how cobimetinib, olaparib, onvan...
Status
Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2019-08-01
Trial ID
NCT04005690
Treatments Being Tested
The intention of the study is to demonstrate superiority of Saruparib (AZD5...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-11-21
Trial ID
NCT06120491
Treatments Being Tested
This research study is studying a new compound, AZD8205, as a possible trea...
Status
Recruiting
Location
Research Site
Start Date
2021-10-18
Trial ID
NCT05123482
The purpose of the study is to demonstrate superiority of Saruparib (AZD530...
Status
Recruiting
Location
Research Site
Start Date
2025-08-06
Trial ID
NCT06952803
Treatments Being Tested